ADCs	Antibody-drug conjugates
mAbs	Monoclonal antibodies
bsADCs	Bispecific ADCs
BSB	Binding-Site Barrier
PRLR	Prolactin receptor
GO	Gemtuzumab ozogamicin
BV	Brentuximab Vedotin
DAR	Drug-to-antibody ratio
T-DM1	Τrastuzumab emtasine
AML	Acute myeloid leukemia
Val-Cit	Valine-citrulline
PABC	Para-amino-benzyloxycarbonyl
PBDs	Pyrrolobenzodiazepines
TRX	1,2,4-trioxolane
uAA	Unnatural amino-acids
mTG	Microbial transglutaminase
SortA	Sortase A
FGE	Formylglycine-generating enzyme
V-ATPase	Vacuolar H+-ATPase
CPT	Camptothecin
AF-HPA	Auristatin F-hydroxypropylamide
MMAE	Monomethyl auristatin E
MMAF	Monomethyl auristatin F
TM-ADC	Trastuzumab–maytansinoid ADC
AAC	Antibody-antibiotic conjugate
MRSA	Methicillin-resistant Staphylococcus aureus
MSSA	Methicillin-susceptible Staphylococcus aureus